Report Detail
Global Pharmaceutical Peptides Services Market Growth (Status and Outlook) 2022-2028
- RnM4495571 |
- 24 November, 2022 |
- Global |
- 101 Pages |
- LPI(LP Information) |
- Medical Industry
The global market for Pharmaceutical Peptides Services is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pharmaceutical Peptides Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pharmaceutical Peptides Services players cover Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma and Peptide Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pharmaceutical Peptides Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pharmaceutical Peptides Services market, with both quantitative and qualitative data, to help readers understand how the Pharmaceutical Peptides Services market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Pharmaceutical Peptides Services market and forecasts the market size by Type (Peptide Drug Discovery, Peptide Drug Bioconjugations and Peptide Lead Optimization), by Application (Enterprise and Research Institute.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Peptide Drug Discovery
Peptide Drug Bioconjugations
Peptide Lead Optimization
Formulation Development
Peptide Drug Screening Service
Total Peptide Library Construction Technology
Other
Segmentation by application
Enterprise
Research Institute
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Creative Peptides
AmbioPharm
3B Pharmaceuticals
ISSAR Pharma
Peptide Institute
WuXi AppTec
JPT Peptide Technologies
CPC Scientific
Red Glead Discovery
Eurofins Scientific
Bio-Synthesis
Bio Basic
CordenPharma
Chapter Introduction
Chapter 1: Scope of Pharmaceutical Peptides Services, Research Methodology, etc.
Chapter 2: Executive Summary, global Pharmaceutical Peptides Services market size and CAGR, Pharmaceutical Peptides Services market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pharmaceutical Peptides Services revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pharmaceutical Peptides Services revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pharmaceutical Peptides Services market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Creative Peptides, AmbioPharm, 3B Pharmaceuticals, ISSAR Pharma, Peptide Institute, WuXi AppTec, JPT Peptide Technologies, CPC Scientific and Red Glead Discovery, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pharmaceutical Peptides Services Market Size 2017-2028
- 2.1.2 Pharmaceutical Peptides Services Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Pharmaceutical Peptides Services Segment by Type
- 2.2.1 Peptide Drug Discovery
- 2.2.2 Peptide Drug Bioconjugations
- 2.2.3 Peptide Lead Optimization
- 2.2.4 Formulation Development
- 2.2.5 Peptide Drug Screening Service
- 2.2.6 Total Peptide Library Construction Technology
- 2.2.7 Other
- 2.3 Pharmaceutical Peptides Services Market Size by Type
- 2.3.1 Pharmaceutical Peptides Services Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Pharmaceutical Peptides Services Market Size Market Share by Type (2017-2022)
- 2.4 Pharmaceutical Peptides Services Segment by Application
- 2.4.1 Enterprise
- 2.4.2 Research Institute
- 2.5 Pharmaceutical Peptides Services Market Size by Application
- 2.5.1 Pharmaceutical Peptides Services Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Pharmaceutical Peptides Services Market Size Market Share by Application (2017-2022)
3 Pharmaceutical Peptides Services Market Size by Player
- 3.1 Pharmaceutical Peptides Services Market Size Market Share by Players
- 3.1.1 Global Pharmaceutical Peptides Services Revenue by Players (2020-2022)
- 3.1.2 Global Pharmaceutical Peptides Services Revenue Market Share by Players (2020-2022)
- 3.2 Global Pharmaceutical Peptides Services Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Peptides Services by Regions
- 4.1 Pharmaceutical Peptides Services Market Size by Regions (2017-2022)
- 4.2 Americas Pharmaceutical Peptides Services Market Size Growth (2017-2022)
- 4.3 APAC Pharmaceutical Peptides Services Market Size Growth (2017-2022)
- 4.4 Europe Pharmaceutical Peptides Services Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Pharmaceutical Peptides Services Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Pharmaceutical Peptides Services Market Size by Country (2017-2022)
- 5.2 Americas Pharmaceutical Peptides Services Market Size by Type (2017-2022)
- 5.3 Americas Pharmaceutical Peptides Services Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Pharmaceutical Peptides Services Market Size by Region (2017-2022)
- 6.2 APAC Pharmaceutical Peptides Services Market Size by Type (2017-2022)
- 6.3 APAC Pharmaceutical Peptides Services Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Pharmaceutical Peptides Services by Country (2017-2022)
- 7.2 Europe Pharmaceutical Peptides Services Market Size by Type (2017-2022)
- 7.3 Europe Pharmaceutical Peptides Services Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Pharmaceutical Peptides Services by Region (2017-2022)
- 8.2 Middle East & Africa Pharmaceutical Peptides Services Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Pharmaceutical Peptides Services Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Pharmaceutical Peptides Services Market Forecast
- 10.1 Global Pharmaceutical Peptides Services Forecast by Regions (2023-2028)
- 10.1.1 Global Pharmaceutical Peptides Services Forecast by Regions (2023-2028)
- 10.1.2 Americas Pharmaceutical Peptides Services Forecast
- 10.1.3 APAC Pharmaceutical Peptides Services Forecast
- 10.1.4 Europe Pharmaceutical Peptides Services Forecast
- 10.1.5 Middle East & Africa Pharmaceutical Peptides Services Forecast
- 10.2 Americas Pharmaceutical Peptides Services Forecast by Country (2023-2028)
- 10.2.1 United States Pharmaceutical Peptides Services Market Forecast
- 10.2.2 Canada Pharmaceutical Peptides Services Market Forecast
- 10.2.3 Mexico Pharmaceutical Peptides Services Market Forecast
- 10.2.4 Brazil Pharmaceutical Peptides Services Market Forecast
- 10.3 APAC Pharmaceutical Peptides Services Forecast by Region (2023-2028)
- 10.3.1 China Pharmaceutical Peptides Services Market Forecast
- 10.3.2 Japan Pharmaceutical Peptides Services Market Forecast
- 10.3.3 Korea Pharmaceutical Peptides Services Market Forecast
- 10.3.4 Southeast Asia Pharmaceutical Peptides Services Market Forecast
- 10.3.5 India Pharmaceutical Peptides Services Market Forecast
- 10.3.6 Australia Pharmaceutical Peptides Services Market Forecast
- 10.4 Europe Pharmaceutical Peptides Services Forecast by Country (2023-2028)
- 10.4.1 Germany Pharmaceutical Peptides Services Market Forecast
- 10.4.2 France Pharmaceutical Peptides Services Market Forecast
- 10.4.3 UK Pharmaceutical Peptides Services Market Forecast
- 10.4.4 Italy Pharmaceutical Peptides Services Market Forecast
- 10.4.5 Russia Pharmaceutical Peptides Services Market Forecast
- 10.5 Middle East & Africa Pharmaceutical Peptides Services Forecast by Region (2023-2028)
- 10.5.1 Egypt Pharmaceutical Peptides Services Market Forecast
- 10.5.2 South Africa Pharmaceutical Peptides Services Market Forecast
- 10.5.3 Israel Pharmaceutical Peptides Services Market Forecast
- 10.5.4 Turkey Pharmaceutical Peptides Services Market Forecast
- 10.5.5 GCC Countries Pharmaceutical Peptides Services Market Forecast
- 10.6 Global Pharmaceutical Peptides Services Forecast by Type (2023-2028)
- 10.7 Global Pharmaceutical Peptides Services Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Creative Peptides
- 11.1.1 Creative Peptides Company Information
- 11.1.2 Creative Peptides Pharmaceutical Peptides Services Product Offered
- 11.1.3 Creative Peptides Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Creative Peptides Main Business Overview
- 11.1.5 Creative Peptides Latest Developments
- 11.2 AmbioPharm
- 11.2.1 AmbioPharm Company Information
- 11.2.2 AmbioPharm Pharmaceutical Peptides Services Product Offered
- 11.2.3 AmbioPharm Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 AmbioPharm Main Business Overview
- 11.2.5 AmbioPharm Latest Developments
- 11.3 3B Pharmaceuticals
- 11.3.1 3B Pharmaceuticals Company Information
- 11.3.2 3B Pharmaceuticals Pharmaceutical Peptides Services Product Offered
- 11.3.3 3B Pharmaceuticals Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 3B Pharmaceuticals Main Business Overview
- 11.3.5 3B Pharmaceuticals Latest Developments
- 11.4 ISSAR Pharma
- 11.4.1 ISSAR Pharma Company Information
- 11.4.2 ISSAR Pharma Pharmaceutical Peptides Services Product Offered
- 11.4.3 ISSAR Pharma Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 ISSAR Pharma Main Business Overview
- 11.4.5 ISSAR Pharma Latest Developments
- 11.5 Peptide Institute
- 11.5.1 Peptide Institute Company Information
- 11.5.2 Peptide Institute Pharmaceutical Peptides Services Product Offered
- 11.5.3 Peptide Institute Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Peptide Institute Main Business Overview
- 11.5.5 Peptide Institute Latest Developments
- 11.6 WuXi AppTec
- 11.6.1 WuXi AppTec Company Information
- 11.6.2 WuXi AppTec Pharmaceutical Peptides Services Product Offered
- 11.6.3 WuXi AppTec Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 WuXi AppTec Main Business Overview
- 11.6.5 WuXi AppTec Latest Developments
- 11.7 JPT Peptide Technologies
- 11.7.1 JPT Peptide Technologies Company Information
- 11.7.2 JPT Peptide Technologies Pharmaceutical Peptides Services Product Offered
- 11.7.3 JPT Peptide Technologies Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 JPT Peptide Technologies Main Business Overview
- 11.7.5 JPT Peptide Technologies Latest Developments
- 11.8 CPC Scientific
- 11.8.1 CPC Scientific Company Information
- 11.8.2 CPC Scientific Pharmaceutical Peptides Services Product Offered
- 11.8.3 CPC Scientific Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 CPC Scientific Main Business Overview
- 11.8.5 CPC Scientific Latest Developments
- 11.9 Red Glead Discovery
- 11.9.1 Red Glead Discovery Company Information
- 11.9.2 Red Glead Discovery Pharmaceutical Peptides Services Product Offered
- 11.9.3 Red Glead Discovery Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Red Glead Discovery Main Business Overview
- 11.9.5 Red Glead Discovery Latest Developments
- 11.10 Eurofins Scientific
- 11.10.1 Eurofins Scientific Company Information
- 11.10.2 Eurofins Scientific Pharmaceutical Peptides Services Product Offered
- 11.10.3 Eurofins Scientific Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Eurofins Scientific Main Business Overview
- 11.10.5 Eurofins Scientific Latest Developments
- 11.11 Bio-Synthesis
- 11.11.1 Bio-Synthesis Company Information
- 11.11.2 Bio-Synthesis Pharmaceutical Peptides Services Product Offered
- 11.11.3 Bio-Synthesis Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Bio-Synthesis Main Business Overview
- 11.11.5 Bio-Synthesis Latest Developments
- 11.12 Bio Basic
- 11.12.1 Bio Basic Company Information
- 11.12.2 Bio Basic Pharmaceutical Peptides Services Product Offered
- 11.12.3 Bio Basic Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Bio Basic Main Business Overview
- 11.12.5 Bio Basic Latest Developments
- 11.13 CordenPharma
- 11.13.1 CordenPharma Company Information
- 11.13.2 CordenPharma Pharmaceutical Peptides Services Product Offered
- 11.13.3 CordenPharma Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 CordenPharma Main Business Overview
- 11.13.5 CordenPharma Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pharmaceutical Peptides Services. Industry analysis & Market Report on Pharmaceutical Peptides Services is a syndicated market report, published as Global Pharmaceutical Peptides Services Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Pharmaceutical Peptides Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
